1-248916636-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_170725.3(PGBD2):c.52G>T(p.Val18Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,614,134 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V18M) has been classified as Uncertain significance.
Frequency
Consequence
NM_170725.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PGBD2 | NM_170725.3 | c.52G>T | p.Val18Leu | missense_variant | 3/3 | ENST00000329291.6 | NP_733843.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PGBD2 | ENST00000329291.6 | c.52G>T | p.Val18Leu | missense_variant | 3/3 | 1 | NM_170725.3 | ENSP00000331643.5 | ||
PGBD2 | ENST00000355360.8 | c.-59-643G>T | intron_variant | 1 | ENSP00000355424.3 | |||||
PGBD2 | ENST00000462488.1 | n.160-643G>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000703 AC: 107AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000131 AC: 33AN: 251410Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135890
GnomAD4 exome AF: 0.0000800 AC: 117AN: 1461866Hom.: 2 Cov.: 31 AF XY: 0.0000756 AC XY: 55AN XY: 727234
GnomAD4 genome AF: 0.000703 AC: 107AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000725 AC XY: 54AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.52G>T (p.V18L) alteration is located in exon 3 (coding exon 2) of the PGBD2 gene. This alteration results from a G to T substitution at nucleotide position 52, causing the valine (V) at amino acid position 18 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at